期刊文献+

蒙医辨证治疗稳定性冠心病的疗效分析 被引量:4

下载PDF
导出
摘要 目的:通过观察炎症细胞因子,探讨蒙医辨证治疗稳定性冠心病的疗效。方法:选取稳定性冠心病患者93例,分为对照组和观察组,对照组47例以冠心病常规治疗,观察组46例以蒙医辨证治疗。疗程结束后对比两组总疗效,观察对炎症因子的影响。结果:治疗后,观察组血清IL-2表达水平降低、TGF-β表达水平升高,IL-2/TGF-β的比值升高,与对照组比较差异有统计学意义(P<0.05)。两组总有效率比较差异有统计学意义(P<0.05)。结论:蒙医辨证治疗稳定性冠心病能显著提高疗效,调节炎症因子水平,缓解炎症反应。
出处 《中国民族医药杂志》 2019年第4期6-7,共2页 Journal of Medicine and Pharmacy of Chinese Minorities
  • 相关文献

参考文献1

二级参考文献20

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 2Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [ J]. J Am Coil Cardiol, 2012, 60(24) : e44 -e164.
  • 3Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology [J]. Eur Heart J, 2013, 34(38) : 2949 -3D03.
  • 4Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascu- lar Angiography and Interventions, and Society of Thoracic Surgeons [ J/OL]. J Am Coll Cardiol, (2014-07-18) [2014-10-15 ] doi : 10. 1016/j. jacc. 2014.07. 017.
  • 5Genders TS, Steyerberg EW, Alkadhi H, et al. A clinical prediction role for the diagnosis of coronary artery disease: validation, updating, and extension. [J]. Eur Heart J, 2011,32(11 ) : 1316 - 1330.
  • 6Pryor DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease [ J]. Ann Intem Med, 1993, 118(2) : 81 -90.
  • 7Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study [J]. J Am Coll Cardiol, 2007, 49(21 ) : 2105 -2111.
  • 8De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease [J]. N Engl J Med, 2014, 371(13) : 1208 -1217.
  • 9Henderson 1LA, Pocock SJ, Clayton TC, et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy [J]. J Am Eoll Cardiol, 2003, 42(7) : 1161 -1170.
  • 10Boden WE, O' Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease [ J ]. N Engl J Med, 2007, 356(15) : 1503 -1516.

共引文献57

同被引文献35

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部